Senior Safety Physician, Oncology @ (September 2023 - January 2026)
Medical Director @ Eli Lilly and Company (February 2023 - September 2023)
Associate Medical Director - SERM (Safety Evaluation and Risk Management) @ (January 2022 - February 2023)
Senior Medical Safety Advisor @ (January 2021 - January 2022)
Pharmacovigilance and Surveillance Medical Advisor - Portuguese Regulatory Authority @ (January 2019 - January 2021)
Medical Doctor @ (January 2013 - January 2021)
Researcher @ (January 2015 - November 2019)
Lecturer in Clinical Pharmacology, Medical School, University of Coimbra, Coimbra, Portugal @ (January 2017 - February 2019)
Pedro Caetano Education
Faculdade de Medicina da Universidade do Porto 2019-2025
Gade Business School 2021-2022
NOVA Medical School - Faculdade de Ciências Médicas 2019-2019
Universidad de Valladolid 2019-2019
Universidade do Porto 2016-2017
Universidade de Coimbra 2015-2017
Pedro Caetano Summary
Pedro Caetano, based in Lausanne, VD, CH, is currently a Executive Safety Physician at Debiopharm. Pedro Caetano brings experience from previous roles at Debiopharm, Eli Lilly and Company, GSK and IQVIA. Pedro Caetano holds a 2019 - 2025 Faculdade de Medicina da Universidade do Porto. Pedro Caetano has 2 emails on RocketReach.
Looking for a different Pedro Caetano?
Find contact details for 700 million professionals.